Lynch Desmond 4

What Happened

• Desmond Lynch, Chief Financial Officer of Astera Labs, was granted two restricted stock unit (RSU) awards on May 1, 2026 totaling 49,584 RSUs (42,501 RSUs + 7,083 RSUs). The Form 4 reports an acquisition price of $0.00 for each grant (RSUs are recorded as awards, not open-market purchases). Each RSU represents a contingent right to receive one share of Astera Labs common stock upon vesting.

Key Details

• Transaction date: May 1, 2026; Form 4 filed May 5, 2026 (filed within the two-business-day window — timely).
• Award amounts: 42,501 RSUs (F1) and 7,083 RSUs (F2), total = 49,584 RSUs.
• Grant price reported: $0.00 per RSU (typical for equity awards; actual taxable/GAAP valuation is separate).
• Vesting (footnotes): F1 — 42,501 RSUs vest 25% on Feb 15, 2027, then the remaining 75% in 12 equal quarterly installments thereafter, subject to continued service. F2 — 7,083 RSUs vest 100% on Feb 15, 2027, subject to continued service.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• No 10b5-1 plan, tax-withholding sale, or late filing is indicated in the provided details.

Context

• RSU grants are a form of compensation and do not equate to an immediate purchase or sale of stock; shares are delivered only if and when RSUs vest. Because vesting is contingent on continued service, these awards are primarily retention/compensation incentives rather than a direct bullish market signal. Investors should view this as routine executive compensation disclosure.